Skip to content

Drug interactions

Eslicarbazepine + Palbociclib

Severity: Moderate

Eslicarbazepine and Palbociclib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine may decrease palbociclib exposure through CYP3A induction, potentially compromising efficacy. The effect is expected to be smaller than with strong inducers.

What this interaction means in plain words

Eslicarbazepine and Palbociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eslicarbazepine belongs to Central Nervous System; Palbociclib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 induction by eslicarbazepine increases palbociclib clearance.

What to do

Prefer a non-inducing antiseizure drug. If combined, monitor tumor response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eslicarbazepine and Palbociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eslicarbazepine with Palbociclib?

MediHelp rates the interaction as moderate. Eslicarbazepine and Palbociclib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Eslicarbazepine may decrease palbociclib exposure through CYP3A induction, potentially compromising efficacy. The effect is expected to be smaller than with strong inducers.

How serious is the interaction between Eslicarbazepine and Palbociclib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a non-inducing antiseizure drug. If combined, monitor tumor response.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in